Stay updated with breaking news from Peter Greenleaf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Fellow Aurinia Shareholders, ILJIN SNT Co., Ltd. and its affiliates (collectively, "ILJIN") is a long-term holder of more than 5% of Aurinia...
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
Achieved $50.3 million in total net revenue and $48.1 million in net product revenue for the first quarter of 2024, representing year over year growth of approximately 46% and 40% respectively, and...
In recognition of Lupus Awareness Month, Aurinia Pharmaceuticals Inc. , today announced several initiatives to improve understanding of the seriousness of lupus nephritis and the need for frequent...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript February 15, 2024 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.18. AUPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to Aurinia […]